The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonifacio, E.
Right arrow Articles by Bingley, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonifacio, E.
Right arrow Articles by Bingley, P. J.
The Journal of Immunology, 1998, 161: 2648-2654.
Copyright © 1998 by The American Association of Immunologists

IA-2 (Islet Cell Antigen 512) Is the Primary Target of Humoral Autoimmunity Against Type 1 Diabetes-Associated Tyrosine Phosphatase Autoantigens1

Ezio Bonifacio2,*, Vito Lampasona{dagger} and Polly J. Bingley{ddagger}

* Department of Medicine 1 and {dagger} Department of Laboratory Medicine, Istituto Scientifico San Raffaele, Milan, Italy; and {ddagger} Department of Medicine, University of Bristol, Bristol, United Kingdom

IA-2 (islet cell Ag 512) and IA-2ß (phogrin/IAR) are related autoantigens associated with type 1 diabetes. To determine the critical regions for autoantibody binding and which of these autoantigens is the primary target, mutant and chimeric constructs were used to characterize Ab epitope binding in sera from 217 new onset patients with type 1 diabetes and sequential samples from 141 islet cell Ab positive first degree relatives of patients. All 22 relatives and 121 of 129 patients with IA-2/IA-2ß Abs had reactivity to IA-2-specific epitopes. These epitopes were in the juxtamembrane region (residues 601–682) and the protein tyrosine phosphatase (PTP)-like domain of IA-2. Chimeras showed that IA-2 residues 795–889 were important for IA-2-specific Ab binding in the PTP-like domain, and mutation of IA-2 residues 877 and 911, previously indicated as relevant for phosphatase activity, also reduced Ab binding. In contrast, Ab binding to IA-2ß was limited to its PTP-like domain, most IA-2ß Abs recognized epitopes shared with IA-2, and only 20 patients and 2 relatives had Abs to IA-2ß-specific epitopes. In 4 relatives, IA-2 and/or IA-2ß Abs developed in follow-up samples. In each of these, Abs to IA-2-specific epitopes were the first detected. In three, spreading to epitopes shared between IA-2 and IA-2ß in subsequent samples was seen. In the 17 relatives who developed type 1 diabetes, progression to disease was associated with reactivity to multiple IA-2/IA-2ß epitopes. These data suggest that IA-2 is the primary phosphatase-like autoantigen associated with type 1 diabetes and that studying autoantibody epitope diversity may assist in disease prediction.




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
A. Makinen, T. Harkonen, J. Ilonen, M. Knip, and the Finnish Pediatric Diabetes Register
Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
Eur. J. Endocrinol., July 1, 2008; 159(1): 19 - 26.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. Kuhle, C. Pohl, M. Mehling, G. Edan, M. S. Freedman, H.-P. Hartung, C. H. Polman, D. H. Miller, X. Montalban, F. Barkhof, et al.
Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis
N. Engl. J. Med., January 25, 2007; 356(4): 371 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S Genovese, E Bazzigaluppi, D Goncalves, A Ciucci, M G Cavallo, F Purrello, M Anello, C M Rotella, G Bardini, O Vaccaro, et al.
Clinical phenotype and {beta}-cell autoimmunity in Italian patients with adult-onset diabetes.
Eur. J. Endocrinol., March 1, 2006; 154(3): 441 - 447.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark
Autoantibodies in Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S52 - S61.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
V. Lampasona, D. Franciotta, R. Furlan, S. Zanaboni, R. Fazio, E. Bonifacio, G. Comi, and G. Martino
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects
Neurology, June 8, 2004; 62(11): 2092 - 2094.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Dromey, S. M. Weenink, G. H. Peters, J. Endl, P. J. Tighe, I. Todd, and M. R. Christie
Mapping of Epitopes for Autoantibodies to the Type 1 Diabetes Autoantigen IA-2 by Peptide Phage Display and Molecular Modeling: Overlap of Antibody and T Cell Determinants
J. Immunol., April 1, 2004; 172(7): 4084 - 4090.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Achenbach, K. Warncke, J. Reiter, H. E. Naserke, A. J.K. Williams, P. J. Bingley, E. Bonifacio, and A.-G. Ziegler
Stratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics
Diabetes, February 1, 2004; 53(2): 384 - 392.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Skoldberg, G. M. Portela-Gomes, L. Grimelius, G. Nilsson, J. Perheentupa, C. Betterle, E. S. Husebye, J. Gustafsson, A. Ronnblom, F. Rorsman, et al.
Histidine Decarboxylase, a Pyridoxal Phosphate-Dependent Enzyme, Is an Autoantigen of Gastric Enterochromaffin-Like Cells
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1445 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Bearzatto, H. Naserke, S. Piquer, K. Koczwara, V. Lampasona, A. Williams, M. R. Christie, P. J. Bingley, A.-G. Ziegler, and E. Bonifacio
Two Distinctly HLA-Associated Contiguous Linear Epitopes Uniquely Expressed Within the Islet Antigen 2 Molecule Are Major Autoantibody Epitopes of the Diabetes-Specific Tyrosine Phosphatase-Like Protein Autoantigens
J. Immunol., April 15, 2002; 168(8): 4202 - 4208.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
C. Roberts, G. A. Roberts, K. Löbner, M. Bearzatto, A. Clark, E. Bonifacio, and M. R. Christie
Expression of the Protein Tyrosine Phosphatase-like Protein IA-2 During Pancreatic Islet Development
J. Histochem. Cytochem., June 1, 2001; 49(6): 767 - 776.
[Abstract] [Full Text]

Home page
 DiabetesHome page
J. Diez, Y. Park, M. Zeller, D. Brown, D. Garza, C. Ricordi, J. Hutton, G. S. Eisenbarth, and A. Pugliese
Differential Splicing of the IA-2 mRNA in Pancreas and Lymphoid Organs as a Permissive Genetic Mechanism for Autoimmunity Against the IA-2 Type 1 Diabetes Autoantigen
Diabetes, April 1, 2001; 50(4): 895 - 900.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
V. Kolm-Litty, S. Berlo, E. Bonifacio, M. Bearzatto, A. M. Engel, M. Christie, A.-G. Ziegler, T. Wild, and J. Endl
Human Monoclonal Antibodies Isolated from Type I Diabetes Patients Define Multiple Epitopes in the Protein Tyrosine Phosphatase-Like IA-2 Antigen
J. Immunol., October 15, 2000; 165(8): 4676 - 4684.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. E. Naserke, A.-G. Ziegler, V. Lampasona, and E. Bonifacio
Early Development and Spreading of Autoantibodies to Epitopes of IA-2 and Their Association with Progression to Type 1 Diabetes
J. Immunol., December 15, 1998; 161(12): 6963 - 6969.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.